Arax Advisory Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Arax Advisory Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$397K	Buy	2,012 +1,034	+106%	+$181K	0.01%	741
2025 Q4	$166K	Sell	978 -429	-30%	-$65.8K	﹤0.01%	1120
2025 Q3	$185K	Buy	1,407 +1,061	+307%	+$127K	﹤0.01%	1293
2025 Q2	$36.7K	Buy	346 +32	+10%	+$3.48K	﹤0.01%	1378
2025 Q1	$39K	Buy	314 +18	+6%	+$2.35K	﹤0.01%	1045
2024 Q4	$36.5K	Buy	296 +13	+5%	+$1.53K	﹤0.01%	991
2024 Q3	$31.5K	Buy	283 +212	+299%	+$23.2K	﹤0.01%	900
2024 Q2	$7.58K	Buy	71 +1	+1%	+$110	﹤0.01%	1399
2024 Q1	$8.43K	Hold	70	–	–	﹤0.01%	806
2023 Q4	$8.61K	Hold	70	–	–	﹤0.01%	782
2023 Q3	$9.06K	Hold	70	–	–	﹤0.01%	743
2023 Q2	$8.68K	Hold	70	–	–	﹤0.01%	737
2023 Q1	$10.2K	Hold	70	–	–	﹤0.01%	683
2022 Q4	$11.2K	Hold	70	–	–	﹤0.01%	637
2022 Q3	$9K	Hold	70	–	–	﹤0.01%	681
2022 Q2	$11K	Hold	70	–	–	﹤0.01%	645
2022 Q1	$11K	Hold	70	–	–	﹤0.01%	645
2021 Q4	$9K	Hold	70	–	–	﹤0.01%	683
2021 Q3	$9K	Buy	+70	New	+$10.6K	﹤0.01%	658
2020 Q4	$1K	Sell	6 -2	-25%	-$298	﹤0.01%	704
2020 Q3	$1K	Hold	8	–	–	﹤0.01%	663
2020 Q2	$1K	Hold	8	–	–	﹤0.01%	652
2020 Q1	$1K	Hold	8	–	–	﹤0.01%	649
2019 Q4	$1K	Hold	8	–	–	﹤0.01%	566
2019 Q3	$1K	Hold	8	–	–	﹤0.01%	568
2019 Q2	$1K	Buy	+8	New	+$1.07K	﹤0.01%	575
2018 Q4	$1K	Hold	8	–	–	﹤0.01%	543
2018 Q3	$1K	Buy	+8	New	+$1.38K	﹤0.01%	601

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Arax Advisory Partners's JAZZ Position: Q1 2026 in Review

Arax Advisory Partners increased its Jazz Pharmaceuticals (JAZZ) stake by 106% in Q1 2026, buying an estimated $181K and bringing the position to 2,012 shares worth $397K. The position accounts for 0.01% of the portfolio, ranked #741.

Arax Advisory Partners first reported a position in JAZZ in Q3 2018 and has held it in 28 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Arax Advisory Partners held 2,012 shares of Jazz Pharmaceuticals worth $397K as of Q1 2026.
Arax Advisory Partners bought 1,034 Jazz Pharmaceuticals shares in Q1 2026, an estimated $181K.
Jazz Pharmaceuticals made up 0.01% of Arax Advisory Partners's portfolio in Q1 2026, its #741 holding.
Arax Advisory Partners first reported a position in Jazz Pharmaceuticals in Q3 2018 and has held it in 28 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.